The Predictive Value of CA-125 and Hb for Ocular Metastasis in Hepatocellular Carcinoma Patients

References

• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.21338
   PubMed Web of Science ®Google Scholar
• Kim JU, Shariff MIF, Crossey MME, et al. Hepatocellular carcinoma: review of disease and tumor biomarkers. World J Hepatol. 2016;8(10):471. doi:10.4254/wjh.v8.i10.471
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.21262
   PubMed Web of Science ®Google Scholar
• Ding XX, Zhu QG, Zhang SM, et al. Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy. Oncotarget. 2017;8(33):55715–55730. doi:10.18632/oncotarget
   PubMedGoogle Scholar
• Mabert K, Cojoc M, Peitzsch C, et al. Cancer biomarker discovery: current status and future perspectives. Int J Radiat Biol. 2014;90(8):659–677. doi:10.3109/09553002.2014.892229
   PubMed Web of Science ®Google Scholar
• Ma L, Xie XW, Wang HY, et al. Clinical evaluation of tumor markers for diagnosis in patients with non-small cell lung cancer in China. Asian Pac J Cancer Prev. 2015;16(12):4891. doi:10.7314/apjcp.2015.16.12.4891
   PubMedGoogle Scholar
• Susana C, Nunez I, Longo M, et al. Serum tumor markers CEA, CYFRA21-1, and CA-125 are associated with worse prognosis in advanced Non–Small-Cell Lung Cancer (NSCLC). Clin Lung Cancer. 2011;12(3):172–179. doi:10.1016/j.cllc.2011.03.019
   PubMed Web of Science ®Google Scholar
• McKeown E, Nelson DW, Johnson EK, et al. Current approaches and challenges for monitoring treatment response in colon and rectal cancer. J Cancer. 2014;5(1):31–43. doi:10.7150/jca.7987
   PubMed Web of Science ®Google Scholar
• Michelson JB, Felberg NT, Shields JA. Carcinoembryonic antigen. Its role in the evaluation of intraocular malignant tumors. Arch Ophthalmol. 1976;94(3):414–416. doi:10.1001/archopht.1976.03910030200005
   PubMedGoogle Scholar
• Chandler PD, Song Y, Lin J, et al. Lipid biomarkers and long-term risk of cancer in the women’s health study. Am J Clin Nutr. 2016;103(6):1397–1407. doi:10.3945/ajcn.115.124321
   PubMed Web of Science ®Google Scholar
• Zamanian-Daryoush M, Lindner D, Tallant TC, et al. The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects. J Biol Chem. 2013;288(29):21237–21252. doi:10.1074/jbc
   PubMed Web of Science ®Google Scholar
• Ma XL, Gao XH, Gong ZJ, et al. Apolipoprotein A1: a novel serum biomarker for predicting the prognosis of hepatocellular carcinoma after curative resection. Oncotarget. 2016;7(43):70654–70668. doi:10.18632/oncotarget.12203
   PubMedGoogle Scholar
• Sirniö P, Väyrynen JP, Klintrup K, et al. Decreased serum apolipoprotein A1 levels are associated with poor survival and systemic inflammatory response in colorectal cancer. Sci Rep. 2017;7(1):1–8. doi:10.1038/s41598-016-0028-x
   PubMed Web of Science ®Google Scholar
• Lin Q, Chen XY, Liu WF, et al. Diagnostic value of CA‐153 and CYFRA 21‐1 in predicting intraocular metastasis in patients with metastatic lung cancer. Cancer Med. 2019;9:1279–1286. doi:10.1002/cam4.2354
   PubMed Web of Science ®Google Scholar
• Tei M, Wakasugi M, Akamatsu H. Choroidal metastasis from early rectal cancer: case report and literature review. Int J Surg Case Rep. 2014;5(12):1278–1281. doi:10.1016/j.ijscr.2014.10.059
   PubMedGoogle Scholar
• Shah SU, Mashayekhi A, Shields CL, et al. Uveal metastasis from lung cancer: clinical features, treatment, and outcome in 194 patients. Ophthalmology. 2014;121(1):352–357. doi:10.1016/j.ophtha.2013.07.014
   PubMed Web of Science ®Google Scholar
• Hazan A, Katz MS, Leder H, et al. Choroidal metastases of choriocarcinoma. Retin Cases Brief Rep. 2014;8(2):95–96. doi:10.1097/ICB.0000000000000012
   PubMedGoogle Scholar
• Cristina NG, Francisco ED, Vanesa RG, et al. Choroidal metastasis from primary bone leiomyosarcoma. Int Ophthalmol. 2015;35(5):721–725. doi:10.1007/s10792-015-0096-0
   PubMed Web of Science ®Google Scholar
• Mercado CL, Toy BC, Kistler HB, et al. Choroidal metastases from cutaneous melanoma. Ophthalmic Surg Lasers Imaging Retina. 2016;47(5):497. doi:10.3928/23258160-20160419-17
   PubMed Web of Science ®Google Scholar
• Fountas A, Tigas S, Giotaki Z, et al. Choroidal metastasis from papillary thyroid cancer: an unusual feature of a common disease. Ann Endocrinol. 2017;78(1):64–66. doi:10.1016/j.ando.2016.09.001
   PubMed Web of Science ®Google Scholar
• Essadi I, Lalya I, Kriet M, et al. Successful management of retinal metastasis from renal cancer with everolimus in a monophthalmic patient: a case report. J Med Case Rep. 2017;11(1):340. doi:10.1186/s13256-017-1501-2
   PubMedGoogle Scholar
• Levison AL, Erenler F, Zhao Y, et al. Late-onset choroidal metastasis from breast cancer. Retin Cases Brief Rep. 2018;12(4):342–345. doi:10.1097/ICB.0000000000000516
   PubMedGoogle Scholar
• Chang SY, Tsai SH, Chen LJ, et al. Choroidal metastasis from esophageal squamous cell carcinoma. Taiwan J Ophthalmol. 2018;8(2):104–107. doi:10.4103/tjo.tjo_80_17
   PubMedGoogle Scholar
• Wayne JD, Lauwers GY, Ikai L, et al. Preoperative predictors of survival after resection of small hepatocellular carcinomas[J]. Ann Surg. 2002;235(5):722–731. doi:10.1097/00000658-200205000-00015
   PubMed Web of Science ®Google Scholar
• Liu J, Yuan Q, Min Y, et al. Apolipoprotein A1 and B as risk factors for development of intraocular metastasis in patients with breast cancer. Cancer Manag Res. 2019;11:2881–2888. doi:10.2147/CMAR.S191352
   PubMed Web of Science ®Google Scholar
• Zhu P, Gong Y, Min Y, et al. The predictive value of high-density lipoprotein for ocular metastases in colorectal cancer patients. Cancer Manag Res. 2019;11:3511–3519. doi:10.2147/CMAR.S194637
   PubMed Web of Science ®Google Scholar
• Min Y, Gong Y, Zhu P, et al. CEA as a risk factor in predicting ocular metastasis from colorectal cancer. J Cancer. 2020;11(1):51–56. doi:10.7150/jca.31196
   PubMed Web of Science ®Google Scholar
• Lin SC, Shih SC, Kao CR, et al. Transcatheter arterial embolization treatment in patients with hepatocellular carcinoma and risk of pulmonary metastasis. World J Gastroenterol. 2003;9(6):1208–1211. doi:10.3748/wjg.v9.i6.1208
   PubMed Web of Science ®Google Scholar
• Ogawa M, Yamamoto T, Kubo S, et al. Clinicopathologic analysis of risk factors for distant metastasis of hepatocellular carcinoma. Hepatol Res. 2004;29(4):228–234. doi:10.1016/j.hepres.2004.04.002
   PubMed Web of Science ®Google Scholar
• Xiang ZL, Zeng ZC, Tang ZY, et al. Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival. BMC Cancer. 2009;9:176. doi:10.1186/1471-2407-9-176
   PubMed Web of Science ®Google Scholar
• Lin ZZ, Jeng YM, Hu FC, et al. Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC. BMC Cancer. 2010;10:461. doi:10.1186/1471-2407-10-461
   PubMed Web of Science ®Google Scholar
• Hsiao SY, Chen SF, Chang CC, et al. Central nervous system involvement in hepatocellular carcinoma: clinical characteristics and comparison of intracranial and spinal metastatic groups. J Clin Neurosci. 2011;18(3):364–368. doi:10.1016/j.jocn.2010.04.037
   PubMed Web of Science ®Google Scholar
• Chua TC, Morris DL. Exploring the role of resection of extrahepatic metastases from hepatocellular carcinoma. Surg Oncol. 2012;21(2):95–101. doi:10.1016/j.suronc.2011.01.005
   PubMed Web of Science ®Google Scholar
• Morimoto Y, Nouso K, Wada N, et al. Involvement of platelets in extrahepatic metastasis of hepatocellular carcinoma. Hepatol Res. 2014;44(14):353–359. doi:10.1111/hepr.12315
   Web of Science ®Google Scholar
• Wan P, Zhang J, Long X, et al. Serum levels of preoperativeα-fetoprotein and CA19-9 predict survival of hepatic carcinoma patients after liver transplantation. Eur J Gastroenterol Hepatol. 2014;26(5):553–561. doi:10.1097/MEG.0000000000000070
   PubMed Web of Science ®Google Scholar
• Chen Y, Gao SG, Chen JM, et al. Risk factors for the long-term efficacy, recurrence, and metastasis in small hepatocellular carcinomas. Cell Biochem Biophys. 2015;72(2):627–631. doi:10.1007/s12013-015-0514-y
   PubMed Web of Science ®Google Scholar
• Lee CH, Chang CJ, Lin YJ, et al. Nomogram predicting extrahepatic metastasis of hepatocellular carcinoma based on commonly available clinical data. JGH Open. 2018;3(1):38–45. doi:10.1002/jgh3.12102
   PubMed Web of Science ®Google Scholar
• Egeblad M, de Visser KE. Sticking together helps cancer to spread. Nature. 2019;566(7745):459–460. doi:10.1038/d41586-019-00341-4
   PubMed Web of Science ®Google Scholar
• Matsuda M, Asakawa M, Amemiya H, et al. Lens culinaris agglutinin-reactive fraction of AFP is a useful prognostic biomarker for survival after repeat hepatic resection for HCC. J Gastroenterol Hepatol. 2011;26(4):731–738. doi:10.1111/j.1440-1746.2010.06532.x
   PubMed Web of Science ®Google Scholar
• Rizzo A, Brandi G. Biochemical predictors of response to immune checkpoint inhibitors in unresectable hepatocellular carcinoma. Cancer Treat Res Commun. 2021;27:100328. doi:10.1016/j.ctarc.2021.100328
   PubMedGoogle Scholar
• De Lorenzo S, Tovoli F, Barbera MA, et al. Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: a proof of concept. Sci Rep. 2018;8(1):9997. doi:10.1038/s41598-018-28337-6
   PubMed Web of Science ®Google Scholar
• Rizzo A, Ricci AD. PD-L1, TMB, and other potential predictors of response to immunotherapy for hepatocellular carcinoma: how can they assist drug clinical trials? Expert Opin Investig Drugs. 2022;31(4):415–423. doi:10.1080/13543784.2021.1972969
   PubMed Web of Science ®Google Scholar